Skip to main content
Article thumbnail
Location of Repository

A Case of Cutaneous Vasculitis with Underlying Hepatitis C and Cryoglobulinaemia

By Cheryl Groves, Clare Devereux and Clifford McMillan


We report a 74 year old lady presenting with cutaneous leukocytoclastic vasculitis. The underlying aetiology was established as chronic hepatitis C infection with associated cryoglobulinaemia. This presented clinically as recurrent cutaneous vasculitic eruptions with absence of any other clinical manifestations. In this case, antiviral treatment to eradicate hepatitis C virus (HCV) was deemed inappropriate given the low necroinflammatory score determined by liver biopsy, absence of other systemic sequelae of cryoglobulinaemia and potential risks of therapy given her age. Currently her cutaneous disease is relatively well controlled with intermittent application of potent topical steroids. This case highlights the need to consider hepatitis C as a potential aetiological factor in all patients with cutaneous vasculitis. We suggest that viral hepatitis screening should be routine in all patients presenting with cutaneous vasculitis

Topics: Case Report
Publisher: The Ulster Medical Society
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. C virus antibodies and evaluation of hepatitis C genotypes in patients with lichen planus. Dermatology 1997;195(1):1-5. Schwaber MJ, Zlotogorski A. Dermatological manifestations of hepatitis 7.
    2. Cryoglobulins are not essential. 11. Ann Rheum Dis 1998;57(1):3-5. Agnello V , Chung RT, Kaplan LM. A role for hepatitis C virus infection 12.
    3. Curr Treat Options Gastroenterol 1999;2(6):481-90. Realdi
    4. Cutaneous 5. vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus induced mixed cryoglobulinemia. Arch Dermatol 1995;131(10):1119-23. Imhof
    5. (2003). Efficacy and safety of rituximab in type II mixed cryoglobulinaemia Blood
    6. Epidemiology of hepatitis C.
    7. experience with chronic hepatitis C in Northern Ireland: epidemiology and response to monotherapy.
    8. (1992). in type II cryoglobulinaemia.
    9. of HCV-related chronic hepatitis. Clin Exp Rheumatol 1995;13(Suppl 13):S7-21. McDougall NI,
    10. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection.
    11. Peginterferon alpha-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358(9286):958-65. Fried
    12. (1993). virus and mixed cryoglobulinaemia.
    13. (1993). virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.